肺癌干细胞的研究现状与进展
被引量:1
Present status and advances in lung cancer stem cells
摘要
肺癌是威胁人类生命和健康最严重的恶性肿瘤,也是导致死亡最常见的肿瘤,其5年生存率约为13%,伴有远处转移的肺癌患者5年生存率仅为2%。近十年来,尽管新的放、化疗方法能有效提高患者的生存质量,但目前并无特别有效的治疗措施可降低肺癌患者的死亡率。许多证据已表明,肿瘤是一种干细胞疾病,干细胞和肿瘤之间有着十分密切的联系,肺癌干细胞的研究在肺肿瘤的治疗及抗肿瘤药物的研究方面具有重要意义。
出处
《中国肺癌杂志》
CAS
2008年第3期473-476,共4页
Chinese Journal of Lung Cancer
参考文献18
-
1王琳琳,贾兰玲,贾心善.大鼠气管损伤修复过程中ABCG2转运蛋白的表达[J].解剖学报,2006,37(2):163-167. 被引量:8
-
2Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells, 2006, 24(3): 506-513.
-
3Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 2005, 65(23): 10946-10951.
-
4O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007, 445(7123): 106-110.
-
5Wang J, Guo LP, Chen LZ, et al. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res, 2007, 67(8): 3716-3724.
-
6Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 2005, 121(6): 823-835.
-
7Ho MM, Ng AV, Lam S, et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res, 2007, 67(10): 4827-4833.
-
8Hilbe W, Dirnhofer S, Oberwasserlechner F, et al. CD133 positive endothelial progenitor cells contribute to the tumour vaseulature in non- small cell lung cancer. J Clin Pathol, 2004, 57(9): 965-969.
-
9Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ, 2008, 15(3): 504-514.
-
10丁强,贾心善,周莹.氟尿嘧啶引起大鼠气管损伤及修复过程的观察及解析[J].中华病理学杂志,2004,33(2):143-145. 被引量:20
二级参考文献28
-
1王恩华,张丽红,邱雪杉,赫明昌,刘闺男,傅志民.地鼠气管上皮损伤后粘液分泌细胞的修复作用[J].解剖科学进展,1996,2(2):179-184. 被引量:1
-
2贾心善 井和久.5 FUによるラツト莨埭pと修瓦^程における莨旨胞の局在[J].日本病理学会会I,2003,93:283-283.
-
3Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo [J] .J Exp Med, 1996,183(4): 1797-1806.
-
4Dunnwald M,Chinnathambi S, Alexandrunas D, et al. Mouse epidermal stem cells proceed through the cell cycle[J]. J Cell Physio,2003,195(2): 194-201.
-
5Zant GV. Studies of hematopoietic stem cells spared by 5-fluorouracil [J]. J Exp Med, 1984,159 ( 3 ): 679-690.
-
6Jia XSH, Hasui K. Location the rat tracheal stem cells after injure induced by 5-FU (abstract)[J]. Proceedings of the Japanese Society of Pathology, 2003,93: 283.賈心善,蓮井和久,5FUによるラツト氣管の损傷と修復過程におけ
-
7Goodell MA,Brose K,Paradis G,et al.Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo[J].J Exp Med,1996,183(4):1797-1806.
-
8Zhou S,Schuetz JD,Bunting KD,et al.The ABC transporter Bcrpl/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype[J].Nat Med,2001,7(9):1028-1034.
-
9Shimano K,Satake M,Okaya A,et al.Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP 1[J].Am J Pathol,2003,163(1):3-9.
-
10Terunuma A,Jackson KL,Kapoor V,et al.Side population keratinocytes resembling bone marrow side population stem cells are distinct from label-retaining keratinocyte stem cells[ J ].J Invest Dermatol,2003,121 (5):1 095-1 110.
共引文献23
-
1廖爱军,贾心善,曲杨.大鼠体内气管损伤修复过程及气管干细胞的定位研究[J].中国组织化学与细胞化学杂志,2005,14(3):349-352. 被引量:6
-
2周莹,贾心善.罗丹明123及P-糖蛋白在人支气管损伤修复过程中的表达(英文)[J].中国现代医学杂志,2005,15(13):1930-1934. 被引量:3
-
3廖爱军,贾心善,周莹.气管干细胞分化过程中Shh信号通路的动态观察[J].中国医科大学学报,2005,34(6):500-501.
-
4周莹,贾心善.人支气管上皮损伤修复过程中Rhodamine 123染色的动态观察[J].解剖学报,2005,36(6):621-624. 被引量:1
-
5王琳琳,贾兰玲,贾心善.大鼠气管损伤修复过程中ABCG2转运蛋白的表达[J].解剖学报,2006,37(2):163-167. 被引量:8
-
6吕威力,贾心善.Wnt-1在大鼠气管干细胞早期增殖与分化过程中的表达[J].解剖学报,2006,37(2):168-171. 被引量:4
-
7廖爱军,贾心善,周莹.气管干细胞增殖分化过程中Shh信号通路的动态观察(英文)[J].中国现代医学杂志,2006,16(7):961-964.
-
8廖爱军,周莹,贾心善.气管干细胞增殖分化动物模型的建立[J].中国现代医学杂志,2006,16(12):1795-1797. 被引量:2
-
9周莹,贾心善,廖爱军.5-氟尿嘧啶诱发人支气管上皮损伤前后P糖蛋白表达的研究[J].中国医科大学学报,2006,35(1):28-30.
-
10丁强,杨扬,贾心善,孙善亮,马小波.ABCG2/Bcrp1可能是大鼠气管上皮干细胞的标记物[J].中国病理生理杂志,2008,24(5):1023-1024.
同被引文献10
-
1刘嵘,濮德敏.雄黄的研究进展[J].时珍国医国药,2007,18(4):982-984. 被引量:38
-
2Frank NY, Schatton T, Frank MH. The therapeutic promise of the cancer stem cell concept . J Clin Invest, 2010; 120(I ): 41 -50.
-
3Kusumbe AP, Bapat SA. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy . Cancer Res, 2009; 69(24): 9245 -9253.
-
4Wang DH, Wei HL, Zhao HS, et al. Arsenic trioxide overcomes apoptosis inhibition in K562/ADM cells by regulating vital components in apoptotic pathway . Pharmacol Res, 2005;52(5): 376 -378.
-
5Bertolini G, Roz L, Perego P, et al. Highly tumorigenic lung cancer CD133 * cells display stem-like features and are spared by cisplatin treatment .Proc Natl Acad Sci USA, 2009; 106(38): 16281 -16286.
-
6Sabisz M, Skladanowski A. Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: implications for drug resistance and in vitro drug screening models. Cell Cycle, 2009 ; 8 ( 19 ) : 3208 - 3217.
-
7Salnikov AV, Gladkich J, Moldenhauer G. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients . lnt J Cancer, 2010; 126(4): 950 958.
-
8刘静,郭文君.肺癌干细胞的研究进展[J].国际病理科学与临床杂志,2008,28(5):433-435. 被引量:2
-
9易娟,陈静,孙静,魏虎来,石建功.小白菊内酯对白血病K562细胞及其干细胞的作用[J].中国中药杂志,2010,35(2):219-222. 被引量:12
-
10王晓波,袭荣刚,李忠亮,任瑞铭,黄世林.纳米级雄黄粉体的制备[J].解放军药学学报,2002,18(3):129-134. 被引量:37
二级引证文献22
-
1李小江,贾英杰,张文治,张莹,李宝乐,黄敏娜,包芳芳,吴建国,朱津丽,娄怡.中医药对肺癌干细胞干预作用的研究概况[J].中医杂志,2012,53(8):708-710. 被引量:4
-
2韩尽斌,刘庆,岳小强,凌昌全(指导),刘鲁明(指导).浅议癌气概念与恶性肿瘤的治疗[J].中医杂志,2012,53(18):1548-1551. 被引量:7
-
3齐元富,李慧杰,聂奔.纳米雄黄对人皮肤鳞状细胞癌A431细胞株增殖抑制及诱导凋亡作用的研究[J].中国实验方剂学杂志,2013,19(4):187-191. 被引量:21
-
4肖调立,田道法,何迎春.鼻咽癌肿瘤干细胞中医药干预研究[J].中国中西医结合耳鼻咽喉科杂志,2013,21(1):1-4. 被引量:2
-
5齐元富,李慧杰,刘寨东.纳米雄黄对肺癌A549细胞增殖影响及其机制的探讨[J].中华肿瘤防治杂志,2013,20(1):27-30. 被引量:17
-
6刘寨东,齐元富,李秀荣.纳米雄黄协同顺铂对人肺癌A_(549)细胞b-FGF、MMP-9表达的影响[J].中国中医药科技,2013,20(3):252-253. 被引量:7
-
7席晓霞,范临兰,田永刚,王蓓,张景科,程杰,魏虎来,吴润.纳米雄黄的抗小鼠原位乳腺癌作用及其机制[J].中国临床药理学与治疗学,2013,18(9):981-987. 被引量:8
-
8刘寨东,朱雪莹,王海媚.纳米雄黄中西医抗肿瘤研究进展[J].中医药导报,2019,25(2):73-75.
-
9李奕诺,田野,赵宇,王晓波,袭荣刚,张治然.纳米雄黄的急性毒性实验[J].解放军药学学报,2015,31(1):13-16. 被引量:9
-
10李秀荣,李慧杰,许艳艳.纳米雄黄对乳腺癌MCF-7细胞侵袭转移恶性行为的影响[J].山东中医药大学学报,2015,39(5):453-455. 被引量:7
-
1黄光武.鼻咽癌研究现状与进展[J].广西医学,2004,26(1):3-5. 被引量:17
-
2张雨康,牛丽娟,王勇.射频消融在肝细胞肝癌临床治疗中的研究现状与进展[J].癌症进展,2017,15(1):15-17. 被引量:14
-
3郑艳.难治性急性白血病研究现状与进展[J].临床医药文献电子杂志,2016,3(20):4129-4130. 被引量:3
-
4韦忠恒.肝癌的微创治疗研究现状与进展[J].右江医学,2011,39(3):348-351. 被引量:2
-
5李伟,李志霞.进展期胃癌的新辅助化疗[J].国际外科学杂志,2008,35(8):540-543. 被引量:1
-
6饶兰(综述),杨桂芳(审校).胃癌干细胞研究现状与进展[J].医学新知,2011,21(1):43-45. 被引量:2
-
7王芳,孙国平.原发性输卵管癌研究现状与进展[J].安徽医药,2010,14(5):500-502. 被引量:12
-
8康宇娟,刘思,宋健,张东伟.乳腺浸润性微乳头状癌的研究现状与进展[J].临床外科杂志,2016,24(2):148-150. 被引量:6
-
9李东迂,苏继荣.胆囊癌病因的研究现状与进展[J].中国现代药物应用,2013,7(21):218-220. 被引量:2
-
10胡林,张沂平.肿瘤干细胞与肿瘤转移和治疗抗性及靶向治疗[J].医学综述,2012,18(12):1841-1845. 被引量:2